The impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on human health has provided a global case study for the need to rapidly understand emerging viruses.
Mass spectrometry (MS)-based workflows across proteomics, glycomics, lipidomics and metabolomics provide multiple approaches for virus research, enabling researchers to develop drug and vaccine programs that mitigate their impact on human health by preventing infection and disease.